Removing small colon polyps costly, unnecessary

By Will Boggs, MD

NEW YORK (Reuters Health) - The surgical removal of small colon polyps found during computed tomography imaging of the colon, or CT colonography, is costly and unnecessary, according to a new study.

“We shouldn’t aggressively pursue sub-centimeter lesions, since the costs, risks, and inconvenience of the subsequent colonoscopy outweighs the clinical importance of these small polyps,” Dr. Perry J. Pickhardt from University of Wisconsin School of Medicine and Public Health in Madison told Reuters Health. “Over time, the few small polyps that matter will declare themselves by showing interval growth,” the researcher added.

Colonoscopy is a colorectal cancer screening test performed with a small camera and under sedation that allows doctors to detect precancerous growths in the colon and remove them on the spot.

Pickhardt and colleagues calculated the relative benefits, harms and costs of CT surveillance versus immediate colonoscopy with polyp removal in a hypothetical population of 100,000 60-year-olds with small growths measuring 6 to 9 millimeters that were found on CT colonography.

By excluding large polyps and masses, CT screening can place a patient in a very low risk category making removal of small polyps probably not warranted, Pickhardt noted in a written statement.

“Approximately 10,000 colonoscopy referrals would be needed for each theoretical cancer death prevented at a cost of nearly $400,000 per life-year gained,” the researcher explained. “We would also expect an additional 10 perforations and probably one death related to these extra colonoscopies.”

“There may be no net gain in terms of lives — just extra costs,” said Pickhardt.

How best to manage small polyps detected at colorectal cancer screening has provoked controversy between radiologists and gastroenterologists, Pickhardt noted. “Patients should be allowed to have the choice between immediate colonoscopy and imaging surveillance for one or two isolated small polyps detected at colorectal cancer screening,” said Pickhardt.

CT colonography is now a recommended test for colorectal cancer screening by the American Cancer Society. “If patients with small polyps are monitored, only five percent of adults undergoing CTC screening will need to undergo immediate invasive colonoscopy,” Pickhardt noted.

SOURCE: American Journal of Radiology, November 2008.


Related Posts:

NEW YORK (Reuters Health) - Screening for colorectal cancer by colonoscopy seems to prevent about two-thirds of deaths from colon cancer, rather than 90 percent as has been widely claimed, a study indicates. In fact, the results show that the benefit of colonoscopy in preventing deaths from colorectal cancer is largely limited to malignancies that occur

Full Post: Real-world colonoscopy benefit seen more limited

By Will Dunham WASHINGTON (Reuters) - Colorectal cancer diagnoses and deaths have fallen in the United States this decade, but the gap in progress between whites and blacks is widening, the American Cancer Society said on Monday. Improvement has come about chiefly due to prevention and early detection through colonoscopy and other screening methods recommended starting at

Full Post: U.S. blacks lag whites in colorectal cancer progress

By Will Dunham WASHINGTON (Reuters) - Primary-care doctors perform colonoscopies just as well as specialists, a finding that could help meet the rising need for this important colorectal cancer screening test, U.S. researchers said on Monday. As populations in the United States and other nations age, the number of people who could benefit from a colonoscopy is

Full Post: Primary-care doctors do colonoscopies well: study

LONDON (Reuters) - A national screening program in Finland has detected about 40 percent of colon cancers early, showing that such tests can make a difference, Finnish researchers reported on Friday. Researchers studied 106,000 men and women aged between 60 and 64 across Finland to examine the effectiveness of a colon cancer screening program started in

Full Post: Study backs Finland’s colon cancer screening

By David Douglas NEW YORK (Reuters Health) - A simplified colorectal cancer screening test that detects tumor DNA in stool is an improvement over an earlier-generation assay, according to North American researchers. “This new version of the stool DNA test offers rather high sensitivity for colorectal cancer using a much simpler assay,” lead investigator Dr. Steven Itzkowitz

Full Post: Improved stool DNA test helps spot colon cancer

Site Navigation

Most Read